Lenire Tinnitus Treatment Device Available in Canada
The bimodal neuromodulation device is now available through select hearing care clinics across five provinces.
The bimodal neuromodulation device is now available through select hearing care clinics across five provinces.
Developed by the National Acoustic Laboratories, the system builds on NAL-NL2 and is designed for more precise, personalized hearing aid fittings.
These evidence-based clinical recommendations emphasizing holistic care provide actionable ways for hearing care professionals to address the complex relationship between hearing and cognition in their practices.Â
The infrared assistive listening solution now meets federal procurement standards, simplifying purchasing for government and regulated industry projects.
The new in-the-canal Elehear Delight OTC model is priced at $369 and designed to address user abandonment due to physical discomfort.
The pivotal clinical trial for the investigational device has now enrolled all 56 participants, moving the company closer to a potential FDA submission.
The partnership makes the bimodal neuromodulation device for tinnitus available through clinics in Philadelphia and Charlotte.
In recognition of National Falls Prevention Awareness Month, Starkey is highlighting the critical link between hearing loss and increased fall risk and how advanced hearing technology can play a life-saving role.
Kasey Kaumans is promoted and Robert C. Luckey joins the company to support channel partners and the AV consultant community.